Keystone Heart Ltd. Announces First Patient Enrolled in New Study to Protect the Brain During TAVR


“The risk of stroke and other neurological damage is a very serious, yet potentially preventable complication associated with TAVR and other cardiovascular procedures,” said Study chair Jeffrey Moses, MD, Professor of Medicine at Columbia University College of Physicians and Surgeons, director of Interventional Cardiac Therapeutics at NewYork-Presbyterian Hospital/Columbia University Medical Center, and director of Advanced Cardiac Therapeutics at St. Francis Heart Center (Roslyn, NY). “Through research of devices such as TriGuard, we hope to prevent future TAVR patients from experiencing complications that can have a grave impact on how they are able to function in their daily lives.”

Read »

Created by keystoneheart 22 weeks 6 days ago – Made popular 22 weeks 3 days ago
Category: News   Tags:

Monetize Your Website


Syndicate content